Vrinda Jethalia

Icahn School of Medicine at Mount Sinai — United States

Medicine · Health Sciences

3h-index32citations25works1.32yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Ferroptosis and cancer prognosis(15), RNA modifications and cancer(15), Cancer, Lipids, and Metabolism(14), Lung Cancer Research Studies(5), Peptidase Inhibition and Analysis(3)

Publications25 total

TET2 mutations drive cell-autonomous type I interferon production and selective advantage through TRIM4 silencing
Blood·2025Open Access
Novel Regulators of Antigen Presentation and Therapeutic reactivation of MHC-I to overcome immune evasion in small cell lung cancer 2043
The Journal of Immunology·2025Open Access
Increasing the Efficacy of ICB by Lurbinectedin Mediated Re-Activation of Tumor Microenvironment in SCLC
Journal of Thoracic Oncology·2025
Figure S2 from SCD1 Inhibition Blocks the AKT–NRF2–SLC7A11 Pathway to Induce Lipid Metabolism Remodeling and Ferroptosis Priming in Lung Adenocarcinoma
2025Open Access
Supplementary Table S2 from SCD1 Inhibition Blocks the AKT–NRF2–SLC7A11 Pathway to Induce Lipid Metabolism Remodeling and Ferroptosis Priming in Lung Adenocarcinoma
2025Open Access
Figure S1 from SCD1 Inhibition Blocks the AKT–NRF2–SLC7A11 Pathway to Induce Lipid Metabolism Remodeling and Ferroptosis Priming in Lung Adenocarcinoma
2025Open Access
Supplementary Table S7 from SCD1 Inhibition Blocks the AKT–NRF2–SLC7A11 Pathway to Induce Lipid Metabolism Remodeling and Ferroptosis Priming in Lung Adenocarcinoma
2025Open Access
Supplementary Table S1 from SCD1 Inhibition Blocks the AKT–NRF2–SLC7A11 Pathway to Induce Lipid Metabolism Remodeling and Ferroptosis Priming in Lung Adenocarcinoma
2025Open Access
Supplementary Table S8 from SCD1 Inhibition Blocks the AKT–NRF2–SLC7A11 Pathway to Induce Lipid Metabolism Remodeling and Ferroptosis Priming in Lung Adenocarcinoma
2025Open Access
Supplementary Table S5 from SCD1 Inhibition Blocks the AKT–NRF2–SLC7A11 Pathway to Induce Lipid Metabolism Remodeling and Ferroptosis Priming in Lung Adenocarcinoma
2025Open Access
Figure S4 from SCD1 Inhibition Blocks the AKT–NRF2–SLC7A11 Pathway to Induce Lipid Metabolism Remodeling and Ferroptosis Priming in Lung Adenocarcinoma
2025Open Access
Supplementary Table S4 from SCD1 Inhibition Blocks the AKT–NRF2–SLC7A11 Pathway to Induce Lipid Metabolism Remodeling and Ferroptosis Priming in Lung Adenocarcinoma
2025Open Access
Supplementary Table S6 from SCD1 Inhibition Blocks the AKT–NRF2–SLC7A11 Pathway to Induce Lipid Metabolism Remodeling and Ferroptosis Priming in Lung Adenocarcinoma
2025Open Access
Supplementary Table S3 from SCD1 Inhibition Blocks the AKT–NRF2–SLC7A11 Pathway to Induce Lipid Metabolism Remodeling and Ferroptosis Priming in Lung Adenocarcinoma
2025Open Access
Data from SCD1 Inhibition Blocks the AKT–NRF2–SLC7A11 Pathway to Induce Lipid Metabolism Remodeling and Ferroptosis Priming in Lung Adenocarcinoma
2025· 1 citedOpen Access
Figure S3 from SCD1 Inhibition Blocks the AKT–NRF2–SLC7A11 Pathway to Induce Lipid Metabolism Remodeling and Ferroptosis Priming in Lung Adenocarcinoma
2025Open Access
Supplementary Table S9 from SCD1 Inhibition Blocks the AKT–NRF2–SLC7A11 Pathway to Induce Lipid Metabolism Remodeling and Ferroptosis Priming in Lung Adenocarcinoma
2025Open Access
Unveiling drivers of MHC repression and therapeutic strategies to counter immune evasion in small cell lung cancer.
Journal of Clinical Oncology·2025
Abstract LB016: Targeting ATM modulates oncogenic pathways and amplifies chemotherapy efficacy in small cell lung cancer
Cancer Research·2025
SCD1 Inhibition Blocks the AKT–NRF2–SLC7A11 Pathway to Induce Lipid Metabolism Remodeling and Ferroptosis Priming in Lung Adenocarcinoma
Cancer Research·2025· 17 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Dan Hasson(25), Triparna Sen(22), Deniz Demircioğlu(21), Utsav Sen(19), Ari M. Vanderwalde(19), Elisa de Stanchina(18), Charles Coleman(17), Andrew Elliott(17), Balázs Halmos(17), Nishant Gandhi(15), Omar Hayatt(15), C. Patrick(15), Mirela Berisa(15), Lewis E. Tomalin(5), Subhamoy Chakraborty(4), Kedwin Ventura(3), Subhasree Sridhar(3), Hilal Özakıncı(3), Misty Dawn Shields(3), Theresa A. Boyle(3)